Ex-Kinetic Concepts CEO Burzik turns her sights to startups
Catherine Burzik, who announced her departure as CEO from Kinetic Concepts 13 months ago, teamed up with Incyte Ventures, working with the venture capital shop to raise $50 million for startups in KCI’s San Antonio, Texas-area base.
Sirona Dental’s CEO succession takes effect
Jeffrey Slovin is taking over the reins at Sirona Dental Systems (NSDQ:SIRO) following ex-chairman & CEO Jost Fischer’s retirement. Solvin, Sirona’s former president, was the ex-CEO of Schick Technologies, which was acquired by Sirona in 2006. In other news at Sirona, Thomas Jetter, a director, is stepping on to the board as a non-executive chairman.
AngioLight sets up a new Asian division under Saxton
Cardiology device company AngioLight said president Gary Saxton will head up the company’s new partnership, Medical Technologies Innovation Asia, in Hong Kong.
NxStage director Nancy Ham bows out
Nancy Ham stepped down as a director at NxStage Medical (NSDQ:NXTM) to set up shop in the corner office at Medicity. Ham, who served on the home hemodialysis company’s board since 2011, resigned Feb. 20.
Holaira stocks up on senior execs
Holaira said it’s hiring 4 new senior executives as part of a product development and clinical trial expansion: Steve Mertens is joining as senior VP of operations; Kari Kubesh as CFO; Mahtab Fatemi as director of regulatory affairs; and Jim Pavliska as VP of clinical affairs.
New board member for Smith & Nephew
Dr. Michael Friedman will join Smith & Nephew‘s (NYSE:SNN) board as a non-executive director April 11. Friedman, previously the CEO of City Hope cancer treatment center, has also worked as senior VP at Pharmacia Corp. and as a deputy commissioner at the FDA.
Biolase takes on new management in regulatory affairs and product development
Bioloase (NSDQ:BLTI), the dental laser manufacturer, appointed Samir Chowdhury, PhD, to general manager and Colleen Boswell as VP of regulatory affairs. Chowdhury, who formerly managed clinical operations at Gamma Medical, will take over Biolase’s product development and engineering. Boswell comes from Sybron Dental Specialties, and will provide regulatory oversight for all of Biolase’s U.S. and international regulatory affairs.
Former CEO of Small Bone taking off executive chairman hat
Anthony Viscogliosi, the founder and executive chairman of Small Bone Innovations, is handing over his title as executive chairman but will stay on as a member of the board to work full-time at Viscogliosi Brothers, a merchant banking and private equity business.
Electromed taps new international general manager
Electromed (NSDQ:ELMD), an airway clearance medical device company, hired Carlo Micheletti as the general manager of international business operations as it looks to expand its reach into international markets.
Cecilia Gonzalo steps into executive role at Essex Woodlands
Private equity firm Essex Woodlands appointed Cecilia Gonzalo as managing director of its healthcare investment team.